{
    "@xmlns:dc": "http://purl.org/dc/elements/1.1/",
    "dc:title": "Progrès dans les maladies osseuses et le métabolisme phospho-calcique",
    "dc:creator": [
        "ALEXANDRE, C",
        "THOMAS, T",
        "LAFAGE-PROUST, M. H",
        "VICO, L"
    ],
    "dc:contributor": [
        "BARDIN, Thomas (Editor)",
        "BOURGEOIS, Pierre (Editor)"
    ],
    "dc:relation": "Revue du rhumatisme (Ed. française) -- Rev. rhum. (Ed. fr.), ISSN 1169-8330, Vol. 74, pp. 65-71",
    "dc:date": "2007",
    "dc:type": [
        "Text",
        "Article"
    ],
    "dc:language": "French",
    "dc:publisher": "Expansion scientifique",
    "dc:format": [
        "print",
        "7 p. ; 33 ref"
    ],
    "dc:subject": [
        {
            "@xml:lang": "fr",
            "#text": "Antiostéoclastique"
        },
        {
            "@xml:lang": "fr",
            "#text": "Antiostéoporotique"
        },
        {
            "@xml:lang": "fr",
            "#text": "Bisphosphonates"
        },
        {
            "@xml:lang": "fr",
            "#text": "Facteur risque"
        },
        {
            "@xml:lang": "fr",
            "#text": "Métabolisme"
        },
        {
            "@xml:lang": "fr",
            "#text": "Os"
        },
        {
            "@xml:lang": "fr",
            "#text": "Ostéoblaste"
        },
        {
            "@xml:lang": "fr",
            "#text": "Ostéocyte"
        },
        {
            "@xml:lang": "fr",
            "#text": "Biphosphonate"
        },
        {
            "@xml:lang": "fr",
            "#text": "Facteurs de risque"
        },
        {
            "@xml:lang": "fr",
            "#text": "Marqueurs"
        },
        {
            "@xml:lang": "fr",
            "#text": "Ostéoblaste"
        },
        {
            "@xml:lang": "fr",
            "#text": "Ostéocyte"
        },
        {
            "@xml:lang": "fr",
            "#text": "Rank"
        },
        {
            "@xml:lang": "en",
            "#text": "Antiosteoclastic agent"
        },
        {
            "@xml:lang": "en",
            "#text": "Antiosteoporotic"
        },
        {
            "@xml:lang": "en",
            "#text": "Bisphosphonates"
        },
        {
            "@xml:lang": "en",
            "#text": "Risk factor"
        },
        {
            "@xml:lang": "en",
            "#text": "Metabolism"
        },
        {
            "@xml:lang": "en",
            "#text": "Bone"
        },
        {
            "@xml:lang": "en",
            "#text": "Osteoblast"
        },
        {
            "@xml:lang": "en",
            "#text": "Osteocyte"
        },
        {
            "@xml:lang": "es",
            "#text": "Antiosteoclástica"
        },
        {
            "@xml:lang": "es",
            "#text": "Antiosteoporótico"
        },
        {
            "@xml:lang": "es",
            "#text": "Bisfosfonatos"
        },
        {
            "@xml:lang": "es",
            "#text": "Factor riesgo"
        },
        {
            "@xml:lang": "es",
            "#text": "Metabolismo"
        },
        {
            "@xml:lang": "es",
            "#text": "Hueso"
        },
        {
            "@xml:lang": "es",
            "#text": "Osteoblasto"
        },
        {
            "@xml:lang": "es",
            "#text": "Osteocito"
        },
        "002B02L: Os, articulations et tissu conjonctif. Antiinflammatoires / Bones, joints and connective tissue. Antiinflammatory agents"
    ],
    "dc:rights": [
        "Inist-CNRS",
        "Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS"
    ],
    "dc:identifier": "Inist-CNRS record number 19947243"
}